Molecule could help treat insulin resistance

Diabetes Call for further research into apelin treatment in diabetes after positive results in mice.

Insulin resistance in diabetes and other metabolic disorders could be treated by a naturally occurring molecule with insulin-like effects, studies by French researchers suggest.

The mechanisms that regulate apelin, a peptide found in a variety of tissues in the body and in the bloodstream, and those that regulate insulin are known to be closely related, but researchers had not previously looked at how apelin affects glucose metabolism in the body.

Professor Isabelle Castan-Laurell and colleagues from the University of Toulouse injected mice intravenously with apelin and found that it rapidly reduced glucose levels in the blood.

They then went on to examine how apelin affected the way that glucose was metabolised in the body. They found that apelin increased glucose turnover and, in response, liver tissue adjusted its glucose production so that normal blood glucose levels were maintained.

In addition, apelin was able to increase insulin-stimulated glucose transport, suggesting that the effects of apelin and insulin are mediated by different mechanisms and can be additive.

'Apelin could represent a promising target in the management of insulin resistance,' Professor Castan-Laurell said.

'Improvement of insulin sensitivity and reduction of blood glucose levels are expected goals for the treatment of type-2 diabetes. We demonstrated that acute injection of apelin was able to improve glucose tolerance in insulin-resistant mice and to increase glucose utilisation in white adipose tissue, skeletal muscles and the heart.'

The effect of long-term treatment with apelin will now need to be studied to provide further insight into the precise role the peptide plays in treating insulin resistance, the researchers said.

The findings may also have wider benefits, they pointed out. 'The contribution of apelin should yield new insights into the physiology and physiopathology of glucose and lipid metabolism.'

Cell Metabolism 2008; 8: 437-45

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Just published

Dr Zoe Norris

GPDF slashes costs and overhauls funding rules to 'restore trust' with GPs

The General Practice Defence Fund (GPDF) has cancelled contracts worth hundreds of...

Churchill Gardens

Scheme from Brazil helps address health inequalities in London practice

A scheme involving community health and wellbeing workers, which is based on a long-standing...

Talking General Practice logo

Podcast: How an initiative from Brazil could help general practice and improve outcomes

Dr Matt Harris and London GP Dr Connie Junghans Minton explain how an initiative...

Medical centre sign

One in three GP practices in Northern Ireland faced serious closure risk in past 18 months

One in three GP practices in Northern Ireland have faced a serious risk of closure...

BMA sign

BMA warns Treasury 'many practices' will close without emergency financial support

GP leaders have urged the Treasury to agree emergency funding to support general...


Practices can use £172m PCN cash to support staff pay rises, GP leaders say

Practices can use their share of Β£172m from the 2023/24 investment and impact fund...